Recent NCI collaborations with industry are highlighted in a May 2019 feature article by BioBuzz entitled: "Three Examples...

Three new cancer therapies recently approved by the Federal Drug Administration (FDA) – avelumab (BAVENCIO®),...

“NCI and Industry: Moving Innovations from the Lab to Patients” was the feature article in March 2019 edition of...

NCI TTC and the Frederick National Laboratory for Cancer Research (FNLCR) will host the 2019 Technology Showcase on June 12....